Product Detail
(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester
Tadalafil Impurity
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Impurity
API Family
Tadalafil
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester Product Information
(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester is listed under Impurity. It is associated with Tadalafil and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-48663.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester
CAS No.
171596-43-3
CAT No.
CS-T-48663
Molecular Formula
C20H18N2O4
Molecular Weight
350.4
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
O=C([C@@H]1CC(C2=CC=CC=C2N3)=C3[C@H](C4=CC=C5C(OCO5)=C4)N1)OC
IUPAC Name
"Methyl (1S,3S)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate"
Hazard Compound
Refer MSDS for complete information.
Description
Overview
Tadalafil derivative. Used in the preparation of pyrazinopyridoindole derivatives for their PDE5 inhibitory activity.
Synonyms
(,4,9-tetrahydro-1H-pyrido[3,4-b]indoleMethyl Ester;(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester;methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
Application Notes
Tadalafil derivative. Used in the preparation of pyrazinopyridoindole derivatives for their PDE5 inhibitory activity.
References
Beghyn, T. et al.: Bioorgan. Med. Chem. Lett. 17, 789(2007)
